MORGAN FOX: Open Payments
NPI 1285208074 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,024 in 97 payments from 15 companies in 2025. Trend: 2023 $596 · 2024 $1,308 · 2025 $2,024
Food & beverage: $1,912Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $376 |
| AstraZeneca Pharmaceuticals LP | 12 | $332 |
| Otsuka America Pharmaceutical, Inc. | 7 | $251 |
| Teva Pharmaceuticals USA, Inc. | 8 | $236 |
| ABBVIE INC. | 15 | $232 |
| Orexo US, Inc. | 11 | $201 |
| Lundbeck LLC | 4 | $78 |
| Novo Nordisk Inc | 2 | $55 |
| Gilead Sciences, Inc. | 2 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
Products named: CAPLYTA, REXULTI, Zubsolv, AIRSUPRA, FARXIGA, VRAYLAR, AUSTEDO XR, INGREZZA.
Industry payments across MI — which companies pay providers there.
